R&D Systems™ Recombinant Human Fibrillin-1/FBN1 Fc Chimera Protein

Description

Measured by its binding ability in a functional ELISA.

When Recombinant Human MFAP4 is immobilized at 0.5 μg/mL (100 μL/well), the concentration of Recombinant Human Fibrillin-1/FBN1 Fc Chimera that produces 50% of the optimal binding response is 0.1 to 0.6 μg/mL.

Specifications

• Accession Number: P35555
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 2200
• Molecular Weight (g/mol): 95 kDa
• Name: ACMICD, Asprosin, FBN, Fibrillin 1, fibrillin 1 (Marfan syndrome), fibrillin 15, fibrillin-1, GPHYSD2, MASS, MFS1, OCTD, SGS, SSKS, WMS, WMS2
• Quantity: 50 μg
• Source:

  Mouse myeloma cell line, NS0-derived human Fibrillin-1/FBN1 protein

  Human Fibrillin-1 (Ala25-Thr660) Accession # P35555IEGRMDHuman IgG1 (Pro100-Lys330)N-terminus C-terminus

• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Endotoxin Level: <0.10 EU per 1 μg of the protein by the LAL method.
• Purity or Quality Grade: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.